Ron Wyden actually said...

In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the heal...

What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?

The problem is that the person negotiating on behalf of the patient should not be getting paid by the other side.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.